Prognosis and Monitoring in Canine Leptospirosis: Knowing What to Expect

The clinical course of leptospirosis in dogs is highly variable, ranging from mild illness to fatal multisystem failure. Prognosis depends largely on the severity of organ involvement at presentation and the development of complications during hospitalization. 

While many dogs recover with appropriate treatment, others may experience persistent organ dysfunction or life-threatening complications such as pulmonary hemorrhage syndrome (LPHS)¹. 

Key Prognostic Indicators 

Certain clinical and laboratory findings have been consistently associated with poorer outcomes. Among these, hyperbilirubinemia stands out as one of the strongest negative prognostic factors, significantly increasing the risk of death or euthanasia¹. 

Coagulation abnormalities, particularly hypocoagulability and disseminated intravascular coagulation (DIC), further worsen prognosis. Respiratory complications, especially LPHS, carry a high mortality rate, reported to be as high as 70% in severe cases¹. 

Renal factors also play a crucial role. Dogs presenting with oliguria or anuria, as well as those with severe azotemia, are more likely to require advanced interventions and have a guarded prognosis. 

The Role of Monitoring in Improving Outcomes 

Close and consistent monitoring is essential for managing leptospirosis effectively. During hospitalization, daily serum biochemistry helps track renal and hepatic recovery, while electrolyte monitoring guides ongoing fluid therapy. 

Packed cell volume and complete blood counts provide insight into anemia, inflammation, and platelet trends. Improvement in platelet counts is often seen within the first week of treatment and can serve as an early indicator of recovery. 

C-reactive protein (CRP) is another useful marker. Declining CRP levels typically correlate with clinical improvement, while persistently elevated levels may indicate ongoing inflammation or secondary complications². 

Recognizing Recovery Patterns¹ 

Recovery from leptospirosis is often gradual rather than immediate. Renal parameters such as creatinine and urea generally return to normal within 10 to 14 days, but complete renal recovery may take much longer. Some dogs may be left with residual chronic kidney disease, requiring long-term management. 

Hepatic recovery tends to follow a slightly different pattern. Liver enzyme activities may normalize relatively quickly, while bilirubin levels decline more slowly. This delayed resolution should not be mistaken for treatment failure. 

Complications That Require Vigilance 

Even with appropriate therapy, complications are common and can significantly impact outcome. These include aspiration pneumonia, pancreatitis, and sepsis, all of which require prompt recognition and management. 

Cardiac involvement, indicated by elevated troponin levels or arrhythmias, may occur secondary to systemic illness rather than direct infection. Similarly, increases in pancreatic enzymes may reflect renal dysfunction rather than true pancreatitis. 

Post-Discharge Monitoring¹ 

Follow-up does not end at discharge. Dogs recovering from leptospirosis should be re-evaluated within one week, including repeat bloodwork and urinalysis. Monitoring helps identify residual kidney dysfunction and ensures that recovery is progressing as expected. 

For dogs with severe AKI, long-term follow-up is essential. These patients should be staged and managed according to chronic kidney disease guidelines if residual impairment persists. 

Clinical Takeaway 

Prognosis in leptospirosis is not fixed at presentation; it evolves with disease progression and response to treatment. Early recognition of negative prognostic indicators, combined with diligent monitoring, allows clinicians to intervene promptly and improve outcomes. 

Ultimately, successful management depends not only on treating the disease but also on anticipating complications and guiding recovery over time. 

Reference 

1. Sykes JE, Francey T, Schuller S, Stoddard RA, Cowgill LD, Moore GE. Updated ACVIM consensus statement on leptospirosis in dogs. Journal of veterinary internal medicine. 2023 Nov;37(6):1966-82. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jvim.16903?utm_source=consensus 
2. Buser FC, Schweighauser A, im Hof‐Gut M, Bigler B, Marti E, Mirkovitch J, Francey T. Evaluation of C‐reactive protein and its kinetics as a prognostic indicator in canine leptospirosis. Journal of Small Animal Practice. 2019 Aug;60(8):477-85. https://doi.org/10.1111/jsap.13004